Our jury of investors and pharma representatives has shortlisted the 30 companies that will participate in NLSDays. These up-and-coming companies will vie for prestigious awards and the chance to woo investors on stage at the event in Copenhagen on November 29-30.
The selected Nordic Stars competitors are small- and medium-sized private companies from the Nordic countries, performing research and development within health, medicine, or life science. At NLSDays, they will each give a four-minute pitch to an audience of investors, industry leaders, and conference delegates. The jury will also be judging the pitches at the event.
Besides the chance to attract new investors and business partners through the pitching and the conference’s partnering system, the competitors are also vying for two prizes, which will be awarded during the NLSDays closing ceremony.
Awards
The Advance Biotech Grant Program – Nordics, which is sponsored by Merck KGaA, Darmstadt, Germany, is a global program that helps biotech startups understand the challenges in the quest to push the next generation of drugs to market. The prize includes bioprocessing technologies and services to an amount of 45,000 EUR.
The NLSDays Nordic Star 2023 Award is given to the company with the highest investment potential, and consists of a 10,000 EUR cash prize and additional in-kind services.
What you get if selected: